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INTRODUCTION
The anterior cruciate ligament (ACL) is the most
frequently injured ligament in the knee and
consequently, the majority of research into knee
ligament injuries has been directed towards the ACL.
While the collateral knee ligaments exhibit strong
healing potential and generally respond well to
conservative treatment, the anterior cruciate ligament
has a poor intrinsic healing ability due to the fact that it
is enveloped by synovial fluid and lacks significant
vascularization (1). Surgical reconstruction is therefore
the most frequent mode of treatment pursued when the
ACL is torn. The patients who experienceACL injuries
are significantly younger and more active than those
who experience many other orthopaedic injuries. The
need for reconstruction options that exhibit longevity in
the face of great stresses is therefore imperative (2).
Historically, options for surgical treatment have
included primary repair with or without synthetic
augmentation and reconstruction using either biological
tissue grafts or prosthetic ligaments. Primary repairs
with or without augmentation have tended to fail at
restoring stability to the knee and are not a common
treatment option today (3). Likewise, prosthetic
replacements have traditionally tended to be inadequate
due to post-surgical complications arising from wear
and degeneration. Hence, biological tissue autograft
reconstruction using the patellar tendon or quadrupled
semitendinosus/gracilis tendons has become the most
popular procedure in surgical treatment of an ACL
rupture. However, the frequency of significant anterior
knee pain post-surgically and high occurrence of flexion
contracture and crepitation in tendon autografts have
kept research interests focused on the further
development of prosthetic ligament implants. A
significant number of early research endeavours into
prosthetic ACL replacements failed due to a poor
understanding of the biomechanical and physiological
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properties of the ACL. Tremendous gains in
understanding have been made in these areas, with
significant progress being made in understanding the
inter-dependence between ACL anatomy, tissue
composition, biomechanics, and the healing processes.
Unfortunately, to date, no prosthesis has proven itself as
a viable alternative to the patellar or hamstring tendon
autografts, currently used in over 90% of ACL
reconstructions. This article reviews some of the major
historical milestones in ACL reconstruction technology
and looks forward to the continuing evolution of this
technology. The literature used for this review was
obtained using the PubMED database with keywords
“anterior cruciate ligament” searched in tandem
separately with “prosthetics” and “tissue engineering.”
It should be noted that many of the studies cited in this
review obtained funding from orthopaedic and
biomaterial companies that sponsored the implant.
SURGICAL REPAIR: ADVANTAGES AND
DISADVANTAGES OF BIOLOGICAL TISSUE
GRAFTS
Bone-patellar tendon-bone (BPTB) and
semitendinosus/gracilis tendon autografts are currently
the most common grafts used in ACL reconstruction.
While the BPTB autografts were the former “gold
standard”, recent studies have identified the quadruple
semitendinosus graft as a comparable option for ACL
reconstruction (4). Advances in hamstring graft fixation
have led to similar strengths of fixation between BPTB
and semitendinosus/gracilis grafts (5). Both techniques
now offer a high degree of strength and stiffness in the
reconstructed ligament. Additionally, use of the
patient’s own tissue eliminates the risk of rejection and
good to excellent results are reported in 85-90% of
patients receiving either of these grafts for ACL
reconstructions. Nonetheless, with patellar tendon
autografts, many patients experience impaired function
and significant morbidity at the donor site including
secondary anterior knee pain, patellar tendonitis,
infrapatellar contracture, and patellar fracture.
Likewise, hamstring weakness and saphenous nerve
injury can be seen secondary to hamstring harvest in
semitendinosus/gracilis autograft ACL reconstruction
(6).
To avoid complications resulting from donor site
morbidity in autograft reconstructions, allograft
reconstruction has also been examined. While
eliminating the donor site morbidity, the use of
allografts is not currently considered advantageous due
to a limited donor tissue supply, delayed biological
incorporation, risks of disease transmission and tissue
rejection. In an attempt to overcome these concerns,
research into the use of synthetic prosthetic ligaments
began over 30 years ago and continues today in hopes
of eliminating donor site morbidity and reducing the
risk of disease transmission and supply shortages. One
of the main obstacles in finding an adequate prosthetic
replacement for the ACL is the longevity of the graft,
with autogenous tissue consistently proving to be a
more durable and long-lasting replacement than the
many biomaterials that have been applied to ACL
replacement (7).
PROSTHETIC BEGINNINGS AND PAST USE
The first attempts at a synthetic ACL reconstruction
were conducted by Alwyn-Smith in 1918 using silk
sutures; they however failed within 3 months (8).
Reconstruction with a prosthetic ligament made of
polytetrafluoroethylene (PTFE) with embedded carbon
or aluminum oxide fibers (Proplast) was first reported
in 1973 (9). Results with this system yielded an average
time to breakage of just over 1 year. A report by James
et al. suggests that only 52% of reconstructions utilizing
this graft yielded satisfactory results (10). Satisfactory
results include all grafts that patients were content with
and had not ruptured at time of lastest follow-up.
Current classification systems for synthetic
replacements of the ACL include grafts, ligament
augmentation devices, or total prosthetics. Grafts
(polyethylene, PTFE), typically fixed at both ends, were
the initial focus of syntheticACL replacement and were
meant to provide stability to the ACL-deficient-knee
until secondary reconstruction procedures gained
popularity (11). Similarly, ligament augmentation
devices (polypropylene, polyester) were intended to
provide immediate protection for autogenous tissue
grafts until revascularization was complete and the
ingrown tissue was capable of withstanding local tensile
and compressive forces. Unfortunately, these devices
may in fact accomplish the opposite of their intended
purpose by stress-shielding autogenous tissue,
preventing it from developing adequate mechanical
strength. Fixed at both ends like a graft, the total
prosthesis was intended as a permanent ACL
replacement without any soft-tissue ingrowth that
would allow the patient to begin aggressive
rehabilitation immediately as no tissue maturation or
revascularization was required. While the implantation
of a full-strength ACL replacement generally led to
excellent short-term results, long-term efficacy results
were poor due to wear and ensuing rupture of the
prosthesis (11).
Combining the mechanical focus provided by these
prior prosthetic approaches with tissue engineering
principles has led to the development of a scaffold
design intended to serve as a foundation for soft tissue
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intended to gradually degenerate as the host tissue
replaces them. Problems associated with the biological
incorporation of scaffolds include variability of tissue
in-growth, immature degeneration of the implant and
insufficient maturation of the host tissue resulting in an
inability of the scaffold to withstand inherent
mechanical stresses placed on the ACL. Current
directions in this area involve the use of tissue
engineering focusing on developing a mechanically and
biologically functional matrix for the scaffold and the
use of in vitro mechanical signals to guide new tissue
development (11). Table 1 summarizes the advantages
of the various prosthetic ACL graft options that have
been attempted and are discussed below.
CARBON FIBRE PROSTHETICS
Some of the earliest attempts to discover an
appropriate alternative to the biological graft resulted in
a variety of carbon fibre prostheses that varied greatly
with respect to material and implantation technique. In
1977, Jenkins et al. were the first to use a flexible
carbon fibre implant, and suggested that the carbon
fibre induced the formation of tendon in animals and
humans (12). However, subsequent studies reported the
generation and migration of carbon wear particles into
the joint space and regional lymph nodes following
implantation of the prosthesis (12). To combat this
problem, attempts were made to coat the carbon fibre
with collagen and absorbable polymers. Of particular
interest was a carbon fibre implant proposed by
Alexander et al. coated with a co-polymer of polylactic
acid (PLA) and polycapralactone (13). The carbon
filaments were thought to act as a scaffold for tissue
ingrowth by evenly distributing and reducing the
interfacial stress between the implant and soft tissue
attachment, while the PLA/polycapralactone would
protect the fibre during implantation. Over time, the
PLA was meant to resorb and the carbon fibres degrade
as new tissue developed, thereby encouraging normal
tissue regeneration without permanently replacing it
(13). A 24-month study involving 82 patients was
conducted by Weiss et al. to further examine the PLA
coated prosthesis using a variety of subjective and
objective measures (pain, stability, function, and
isokinetic strength testing), which revealed significant
improvements over the duration of the study (14).
Arthroscopic evaluation demonstrated collagenous
tissue ingrowth, confirmed by histological studies, to be
composed of Type I and III collagen in similar
proportions to that found in normal healing ligamentous
tissue (14).
A similar design was used in the Surgicraft ABC
prosthetic ACL (Surgicraft Ltd., Redditch UK)
composed of carbon and polyester fibres oriented in a
partial braid by a zig-zag pattern. However, a study by
O’Brien et al. with an average follow-up of 34 months
showed only 11 of 31 knees (41%) had good results
defined as a Lysholm score greater than 76. The
Lysholm knee score is an outcome measure that
assesses knee function on a 100 point scale. The
Prosthesis Advantages Disadvantages
Carbon
Reduction and even distribution of stress between graft
and soft tissue attachment
Polylactic acid coat protects graft during implantation
Encourages ingrowth of collagen into implant
Migration of carbon wear particles
Unacceptable incidence of implant stretching and rupture
led to poor long-term functional outcomes
Gore-Tex Tensile strength 3X native human ACL Progressive long-term loosening
Dacron Polyester coating serves to protect implant from abrasion Poor long-term stability
Leeds-Keio
Artificial
Ligament
Acts as a scaffold for soft tissue ingrowth
Excellent max. tensile strength which
exceeds that of native ACL
Acts as more of a load-bearing prosthesis,
allowing for fibrous tissue ingrowth
Large number of long-term graft ruptures
Kennedy
Ligament
Augmentation
Device
Protects autogenous graft from excessive stresses
Weak implant-graft interface
Propensity to cause intra-articular inflam. response
and resulting synovitis and effusions
LARS Ligament
Mimics natural ACL structure and orientation
Reduces shearing forces on the implant
Porosity encourages tissue ingrowth
Residual post-operative laxity still present
No long-term follow-up studies yet
Tissue-engineered
Scaffolds
Duplicate mechanical & structural properties
of native ACL
Restoration of normal knee joint kinematics
Implant can resemble normal ACL over time
Loses strength over time
Allogenecity of collagen scaffolds can lead to rejection
Consistent reprod. difficult due to batch-to-batch variability
Collagen not as modifiable as biodegradable polymers
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authors also noted unacceptable stretching and
complete rupture as major complications and concluded
that the implant is unsuitable for clinical use (15).
GORE-TEX PERMANENT PROSTHESIS
The Gore-Tex ligament prosthesis is composed of a
single long fiber of expanded polytetrafluoroethylene
(PTFE) arranged into loops. Extensive mechanical
testing has shown that the resulting ultimate tensile
strength is about 3 times that of the humanACL and the
results from cyclical creep tests and bending fatigue
testing seem to identify Gore-Tex as the strongest
synthetic ACL replacement in terms of pure material
stability (16). Bolton and Bruchman reported that 129
out of 130 patients receiving a high strength PTFE
ligament showed improved knee stability at 15 months
or less (16). Glousman et al. reported an initial
improvement upon physical examination and subjective
scores. However, at mean follow-up of 18 months, they
reported a progressive loosening of the prosthesis (17).
Similarly, Woods et al. presented 2- and 3-year follow-
up of Gore-Tex ACL reconstructions and showed a
similar pattern of early improvement post-operatively,
but deterioration over time. They reported an overall
failure rate of 33% at 3-year follow-up (18). Indelicato
et al.’s follow-up of Gore-Tex implant ACL
reconstructions showed a 90% success rate at 2 years
versus only a 76% success rate at 3 years or more (19).
Despite similar reports describing complications with
the Gore-Tex ACL prosthesis, subjective results in
several studies remain acceptable at 60-80 % (17, 19).
The Gore-Tex ACL prosthesis is currently FDA
approved for use in patients who have had a failed
autogenous intra-articular graft procedure.
DACRON
With its success as a vascular surgery implant (20),
various forms of Dacron grafts have been developed as
a scaffold for ACL replacements. The implant is a
composite of four tightly woven polyester strips
wrapped in a sheath of loosely woven velour, designed
to minimize abrasion of the graft and act as a scaffold
for fibrous tissue ingrowth. A report by Lukianov et al.
reviewed the short-term follow-up (mean 28 months) of
41 patients who underwentACLreconstruction with the
Stryker Dacron ligament prosthesis (3). Seventy-five
percent of the patients were found to have a negative
Lachman, anterior drawer, and pivot shift at their most
recent follow-up. However, Richmond et al. reported
failure rates of 37.1% in a study of Dacron
reconstruction with mean long-term follow-up of 50
months (21). Likewise, Barrett et al. reported higher
failure rates of 47.5% after a four-year follow-up period
(22). A clinical study by Lopez-Vazquez et al.
examiningACLreconstruction with a Dacron prosthesis
showed a similar deterioration of results after the first
post-operative year (23). With the initial short-term
strength shown by these grafts offset by their poor long-
term stability, Dacron grafts should not be considered a
viable alternative for ACL reconstruction.
LEEDS-KEIO ARTIFICIAL LIGAMENT
With the desire to design a graft that combined the
properties of a permanent prosthesis and a tissue-
promoting scaffold, Fujikawa and Seedhom developed
the Leeds-Keio artificial ligament: a polyester mesh-
like structure anchored to the femur and tibia with bone
plugs (24). This mesh was intended as a scaffold for
soft tissue ingrowth through the intra-articular and
extra-articular sections of the ligament, eventually
uniting the bone plugs. The implant was considered
sufficiently flexible to be effective with a maximal
tensile strength of approximately 2100 Newtons (N),
which significantly exceeds that of the average young
adults’ natural ACL (about 1730 N) (24). Initial
descriptions from the inventors also described minimal
articular wear with the ligament (24). The inventors of
this graft have reported successful clinical results with
arthroscopic observations documenting neoligamentous
tissue within the implanted Dacron scaffold. Other
investigators, however, have reported the ingrowth of
non-aligned fibrous tissue (i.e. non-neoligamentous
tissue) within the device after implantation and
suggested that the Leeds-Keio ligament did not serve as
a true scaffolding graft, but instead behaved as a
permanent load-bearing prosthesis, subject to long-term
failure in the joint (25).
McLoughlin and Smith presented a 3.8 year follow-up
study of 25 patients implanted with the Leeds-Keio
ligament for chronic ACL instability. They reported a
low complication rate and considerable success in the
elimination of instability after finding good post-
operative results with the anterior drawer test using an
arthrometer at 90° of flexion (26). Nevertheless,
ensuing long-term follow-up studies showed a
deterioration of results after the first post-operative year
and a large number of long-term graft ruptures despite
excellent early results in stability testing and on the
Lysholm scale (27). These findings were similar to
earlier results reported by Schindhelm, who found that
good early results in a sheep model were not maintained
(28). Due to the number of long-term graft ruptures and
the lack of long-term stability provided, the Leeds-Keio
ligament is no longer suitable for reconstruction of the
human ACL (27, 28).33 Vol. 11 No. 1 Anterior Cruciate Ligament Reconstruction: A Look at Prosthetics
KENNEDY LIGAMENT AUGMENTATION
DEVICE (LAD)
Kennedy et al. introduced the concept of the Ligament
Augmentation Device (LAD) in 1980 (29). The graft,
composed of a band-like braid of polypropylene, was
originally developed to reinforce the area of pre-patellar
tissue considered to be a weak area of autogenous
patellar tendon grafts. Use of this prosthesis employed
the MacIntosh/Marshall transfer of a portion of the
rectus femoris tendon, pre-patellar tissue, and central
third of the patellar tendon in an over-the-top fashion
(30). Originally, the graft was developed to protect the
autogenous tissue graft from excessive stresses during
the initial remodelling phase (characterized by
degeneration and revascularization), allowing for
earlier resumption of pre-operative activity levels (29).
Research has shown that the percentage of load
accepted by the LAD varies according to the type of
graft employed and method of reconstruction.
Comparisons of the patellar tendon and
semitendinosus/gracilis LAD composite grafts revealed
that the LAD will accept approximately 28% and 45%
of the applied load, respectively (31). To prevent
excessive stress shielding that would otherwise prevent
the autogenous tissue from developing a normal
functional tensile strength, the LAD was attached to the
bone at only one end. Despite a promising beginning,
the suture interface between the LAD and the graft was
identified as the weak link of the composite.
Whether collagen fibres become truly incorporated
into the LAD remains a controversial issue. Most
histological evidence has been derived from animal
studies and thus may not be fully indicative of results in
humans. Nevertheless, this evidence seems to point to
adequate longitudinal collagenization of the graft with
inconclusive results on whether or not collagen
ingrowth within the LAD has occurred (32).
Furthermore, as an intra-articular foreign body, the
LAD has been reported to induce an inflammatory
response characterized by foreign body giant cells and
macrophages in the surrounding tissue. A review by
Kumar et al. reported that the majority of complications
seen following use of the LAD were characterized as
effusions and reactive synovitis, likely a result of LAD-
induced inflammatory response (23). The decline in use
of the aforementioned MacIntosh/Marshall transfer,
combined with the weak graft-prosthetic suture
interface and propensity of the LAD to cause high rates
of post-operative synovitis have resulted in a lack of
widespread use of the device.
THE FUTURE: LIGAMENT ADVANCED
REINFORCEMENT SYSTEM (LARS)
ARTIFICIAL LIGAMENT
The Ligament Advanced Reinforcement System
(LARS) (Arc-sur-Tille, France) artificial ligament
consists of fibres made of polyethylene terephthalate
(PET). An intra-osseous segment is composed of
longitudinal fibres bound together by a transverse
knitted structure while an intra-articular segment is
composed of parallel longitudinal fibres twisted at 90°.
The main innovation of this artificial ligament lies in its
ability to mimic the natural ligamentous structure and
reduce shearing forces by orientating the free fibers of
the intra-articular portion of the graft clockwise or
counter-clockwise for use in right and left knees,
respectively. Furthermore, the PET fibres of the intra-
articular segment are designed to encourage tissue
ingrowth due to the porosity of the material, allowing
ingrowth from the surrounding osseous tunnels.
Ideally, such tissue ingrowth between the ligament
fibres would contribute to the viscoelasticity of the graft
and protect against friction at the opening of the bony
canal and between the fibres themselves (1).
Astudy by Lavoie et al. examinedACLreconstruction
with the use of the LARS artificial ligament. Thirty-
eight of forty-seven patients suffered from chronic
ruptures of the ACL, while nine others presented with
acute or subacute ruptures at a mean follow-up of 21.9
months. Six patients had previously had an
unsuccessful ACL reconstruction. The Knee
Osteoarthritis Outcome Score (KOOS) was
administered to assess patients’opinions regarding their
knee, while a modified International Knee
Documentation Committee (IKDC) scoring system was
used to examine knee stability. The IKDC form initially
consisted of seven knee-related parameters that were
each rated as either normal, nearly normal, abnormal,
and severely abnormal. The worst score amongst the
seven categories determined the final score. The form
was later modified in 2001 to include subjective factors
such as symptoms, sports activities, and ability to
function. The Tegner activity scale, a subjective ten
point activity scale, was obtained to assess patient
activity levels. A Telos radiographic stress system was
used to examine anterior knee displacement, which
involves obtaining radiographs with the knee in ninety
degrees of flexion and a posterior force applied to the
knee. When results are compared to the normal knee,
this test helps in the assessment of post-operative laxity
in the reconstructed knee which may indicate that the
graft is failing. None of the patients presented
symptoms of synovitis, but longer follow-up time is
required to properly draw conclusions with respect to
patient outcome. Although Tegner scores improved34 McGill Journal of Medicine 2008
significantly following surgery, no patients returned to
pre-injury activity levels. Data obtained by the KOOS
demonstrated patient satisfaction ranged from 73.5 to
93.0 %. In comparison to the uninjured knee, post-
operative Telos stress radiography and the Lachman test
indicated an average posterior-anterior displacement of
7.3 mm for the involved knee (28).
A more complete examination of the LARS artificial
ligament was provided in a subsequent study by the
same authors. Nau et al. conducted a two-year follow-
up randomized controlled trial that compared the BPTB
autograft with the LARS artificial ligament method of
ACL reconstruction in 53 patients with chronic
instability (1). Like the preceding study, assessments
included clinical examination, anterior laxity testing, as
well as the KOOS, IKDC, and Tegner scores. In
particular, IKDC evaluation revealed little significant
difference between the two methods. Follow-up values
for instrumented laxity testing were greater in the
LARS group. While similar overall results were
obtained for both groups, these results may suggest that
a full return to activity may be hastened by using the
LARS artificial ligament rather than the conventional
BPTB technique (1).
Another recent study by Talbot et al. examined the use
of the LARS artificial ligament for ligament
reconstruction in knee dislocations (2). Twenty patients
were included with a mean follow-up of 27.4 months.
Each patient was evaluated using the Lysholm score,
underwent clinical examination to identify ligamentous
laxity and range of motion, and completed the ACL
quality of life (ACL-QoL) questionnaire. The mean
Lysholm score was 71.7, which is lower than scores
reported by several other studies (range of 74.7 to 91.3)
investigating the outcomes of knee dislocations treated
with surgery as reported by Fanelli (35). Following the
same trend, Telos radiometry revealed a mean residual
laxity of 5 mm in patients post-surgery, which is also
greater than these previously reported results. The
average range of motion post-surgery was 118ﾰ with a
mean fixed flexion contracture of 2ﾰ (2).
Although preliminary investigations into the use of
the LARS artificial ligament have been encouraging,
concerns regarding the risk of rupture remain and must
be addressed through long-term follow-up studies.
TISSUE ENGINEERINGADVANCES
Permanent synthetic prostheses are capable of
duplicating the mechanical and structural properties of
theACL. However, they generally tend to lose strength
with time. Tissue-based or tissue-aided implants offer
the additional possibility of the restoration of normal
joint kinematics while the mechanical behaviour of
these implants is expected to improve over time as
tissues are remodelled within the knee (36). An ideal
ACL scaffold must meet the immediate functional
mechanical demands within the reconstructed knee,
however, they must also degrade at a rate similar to that
of tissue ingrowth. Accordingly, the ACL scaffold
should lose its mechanical integrity while allowing the
remodelled tissues to gain strength and accept an
increasing amount of the mechanical demands placed
on the ACL. Current research into this novel tissue-
engineering approach has focused on seeding either
collagen-based scaffolds or synthetic biodegradable
polymers with a variety of different cell types. In hopes
of stimulating early healing, reducing biomaterial-
related inflammatory response and improving
neoligament formation, several researchers have sought
to adopt a cell sheeting technique to improve the
performance of the synthetic ACL scaffold.
Several groups have conducted experiments on this
tissue-engineered approach to ACL ligament
reconstruction using both fibroblast-seeded synthetic
scaffolds and collagen-based prosthetics (37, 38).
Bellincampi et al. measured the ingrowth characteristics
of rabbit fibroblasts on skin and ACL scaffolds (39).
Subsequent in vivo studies suggested that fibroblast-
seeded collagen scaffolds were viable after re-
implantation into the donor rabbit. The major
limitations of these approaches are the allogenicity of
the collagen scaffolds, often leading to further
complications. Collagen-based constructs also suffer
from batch-to-batch variability, making consistent
reproduction of these prostheses difficult. Collagen
does not offer the same flexibility for modification that
is reported with the technology of biodegradable
polymers (6).
As an alternative to the scaffolds made of non-
degradable polymers, investigators have begun to
examine biodegradable materials that would provide
immediate stabilization to the repaired ligament but
would also act as a scaffold for the ingrowth and/or
replacement by host cells. Cao et al. described the
generation of neo-tendons in a nude mice model by
implanting polyglycolic acid (PGA) scaffolds seeded
with bovine tendon fibroblasts in the subcutaneous
space of athymic mice (40). Using a similar system,
Koski et al. reported the formation of ligament-like
structures when fibroblasts isolated from bovine
cruciate ligaments were seeded onto PGA scaffolds and
implanted subcutaneously in nude mice (6). In both
studies, the tissue developed histological characteristics
similar to normal tendon and ligament over time.
Ouyang et al. reported that bone marrow stromal cells
(bMSCs) seeded onto poly-lactic and -glycolic acid
(PLGA) scaffolds grew as a multi-layer of cells
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themselves. They also noted that the cell sheet formed
faster than scaffolds seeded with terminally
differentiated cells, such as fibroblasts and smooth
muscle cells (41). They reported that degradation of the
scaffolds occurred over time, as indicated by a decrease
in failure load. Altman et al. seeded 6-cord silk
scaffolds with human bone marrow stromal cells and
cultured them for 14-21 days. Their results similarly
suggested a slow degradation of the scaffolds.
However, fatigue analysis and subsequent regression
analysis revealed an expected matrix lifetime equivalent
to 1 year in vivo. While these reports are an estimate,
the authors suggest that this is a marked improvement
compared to similar studies using collagen scaffolds
(36).
The future of tissue engineering may also require a
significant contribution from cell-specific growth
factors influencing the maturation and homeostasis of
the healing response of ligament tissue. Studies have
suggested that individual growth factors may have an
important effect on cell division and enhance ligament
healing, while others have pointed to the synergistic
effect of a combination of growth factors as important
to cell outgrowth in ACL explants (42, 43). In a study
observing the effects of several growth factors on the
cell migration, proliferation and collagen production in
human ACL cells, Murray et al. suggested that specific
dose-response relationships may exist for the optimal
activity of each growth factor (44). These authors
observed that the addition of transforming growth factor
(TGF)ʲ-1 led to an increased cell population, as well as
increased collagen and smooth muscle actin production
in human ACL cells cultured on top of a collagen-
glycosaminoglycan scaffold. Despite the complex
nature of the inter-dependent factors at play during the
recovery and rehabilitative period following an ACL
reconstruction, much of the literature today suggests
that tissue engineering techniques will lead to a new
generation of ACL replacements, capable of
regenerating a mechanically robust and natural ACL.
COMPUTER-ASSISTED ACL
RECONSTRUCTION
In an attempt to improve the accuracy and
reproducibility of ACL graft placement, several groups
have turned to computer-assisted surgery in an attempt
to reduce the incidence of graft failure (45, 46). These
systems are capable of modeling the placement and
predicting the impingement of an ACL graft based on
intra-operative anatomical landmarks and signals
received at an opto-electric camera. These studies
reported that experience level did not affect the
placement of the tunnels. Computer-assisted ACL
replacement reduces variance in tunnel placement and
allows residents and less experienced surgeons to limit
complications and control tunnel positioning (46).
Based on the success of navigation systems for total
knee and hip replacements, the use of computer-assisted
ACL reconstruction may lead to similarly dramatic
improvements in technical and functional outcomes.
CONCLUSION
Satisfactory prosthetic replacement of the ACL has
been a focus of orthopaedic research endeavours for the
past thirty years. Desires to provide immediate mobility
and strength to the ACL-deficient knee while avoiding
the donor site morbidity caused by the commonly used
autograft surgical techniques continually drive new
research initiatives. Most of the grafts that have been
developed to date have failed due to unsatisfactory
long-term physiologic and functional performance.
Most permanent ACL prostheses are prone to creep,
fatigue, and mechanical failure within several years
after implantation (40). Tissue ingrowth scaffolds and
ligament augmentation devices require further
refinement to provide effective mechanical support
while avoiding stress-shielding of the host tissue. In
view of these factors, prosthetics are not widely used
today in ACL reconstruction, and autogenous tissue
grafts remain the gold standard used by the majority of
surgeons. Perhaps development of resorbable, tissue-
inducing and cell-seeded biomaterials will improve the
long-term biomechanical performance of the
reconstructed anterior cruciate ligament. Advances in
tissue engineering combined with developments in
molecular biology and gene therapy may couple with
the rapid gains in computer-assisted surgery to provide
improved options for the ACL-deficient knee, with a
greater potential to restore its pre-injury state.
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